Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase.
It would need to be repurchased by the trainee if not completed in the allotted time period.
This course is no longer available.
You will need to repurchase if you wish to take the course again.

Description

Locoregional therapy for the treatment and palliation of both primary and metastatic liver malignancy has undergone exponential growth within the past decade as both therapeutic technologies and data continue to advance at an exciting pace. The indication and utilization of transarterial radioembolization has expanded to include neoadjuvant and definitive applications within management algorithms. Methodical interrogation of hepatic tumoral neovascularity and liver angiosomal manipulation has allowed for ablative radioembolization to generate early outcomes typically reserved for surgical resection but performed safely in the outpatient setting with negligible morbidity.

Dr. Beau Toskich - Dr. Beau Toskich is an Assistant professor and Associate Fellowship Director for the division of vascular and interventional radiology at the University of Florida College of Medicine. He is also research affiliate faculty at the University of Florida College of Veterinary Medicine. His research interests include locoregional therapies for primary liver, lung, and kindey cancer, management of oligometastatic disease, and neoadjuvant applications of transarterial technology. In addition to interventional oncology, Dr. Toskich specializes in management of acute and chronic venothromboembolic disease, portal hypertension, and arteriovenous malformations. He lives in Gainesville with his wife Jodi and their rescue greyhound, Violet.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s: